Cargando…
Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery
The introduction of directly acting antiviral agents (DAAs) has produced significant improvements in the ability to cure chronic hepatitis C infection. However, with over 2% of the world’s population infected with HCV, complications arising from the development of cirrhosis of the liver, chronic hep...
Autores principales: | Christiansen, D., Earnest-Silveira, L., Grubor-Bauk, B., Wijesundara, D. K., Boo, I., Ramsland, P. A., Vincan, E., Drummer, H. E., Gowans, E. J., Torresi, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592879/ https://www.ncbi.nlm.nih.gov/pubmed/31239471 http://dx.doi.org/10.1038/s41598-019-45461-z |
Ejemplares similares
-
Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine
por: Christiansen, D., et al.
Publicado: (2018) -
A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2019) -
Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2017) -
The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
por: Torresi, Joseph
Publicado: (2017) -
Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1
por: Wijesundara, Danushka K., et al.
Publicado: (2017)